DelveInsight’s Systemic Lupus Erythematosus Market Insights report includes a comprehensive understanding of current treatment practices, emerging systemic lupus erythematosus drugs, market share of ...
In patients with systemic lupus erythematosus, impaired upper limb function and difficulty performing daily activities are linked to various quality-of-life domains.
A first clinical study suggests allogeneic CD19-targeted CAR-T cell therapy can safely induce durable remission in patients ...
Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder that predisposes affected individuals to an elevated risk of cardiovascular disease (CVD). The intricate interplay of traditional ...
Upper Limb Dysfunction Linked to Poor Quality of Life in SLE In patients with systemic lupus erythematosus, impaired upper limb function and difficulty performing daily activities are linked to ...
Lupus affects different people in different ways, and skin problems like rashes or sores are common. In a new study, people with systemic lupus erythematosus (SLE) were found to be at higher risk for ...
Please provide your email address to receive an email when new articles are posted on . Early mycophenolate mofetil in newly diagnosed SLE led to fewer severe flares and lower incidence of lupus ...
Over 3.4 million people globally are affected by SLE, and it is one of the leading causes of death in young women in the US ...
New study finds systemic lupus erythematosus associated with adverse outcomes in right heart failure
In a new study, right heart failure (RHF) hospitalizations of people with systemic lupus erythematosus (SLE) was associated with higher in-hospital mortality and non-fatal adverse outcomes. Lupus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results